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Infections caused by theMycobacterium avium complex (MAC) are on the rise in both human and veterinary
medicine. A means of effectively discriminating among closely related yet pathogenetically diverse members of
the MAC would enable better diagnosis and treatment as well as further our understanding of the epidemiology
of these pathogens. In this study, a five-target multiplex PCR designed to discriminate MAC organisms isolated
from liquid culture media was developed. This MAC multiplex was designed to amplify a 16S rRNA gene target
common to all Mycobacterium species, a chromosomal target called DT1 that is unique to M. avium subsp.
avium serotypes 2 and 3, to M. avium subsp. silvaticum, and to M. intracellulare, and three insertion sequences,
IS900, IS901, and IS1311. The pattern of amplification results allowed determination of whether isolates were
mycobacteria, whether they were members of the MAC, and whether they belonged to one of three major MAC
subspecies, M. avium subsp. paratuberculosis, M. avium subsp. avium, and M. avium subsp. hominissuis.
Analytical sensitivity was 10 fg of M. avium subsp. paratuberculosis genomic DNA, 5 to 10 fg of M. avium subsp.
avium genomic DNA, and 2 to 5 fg of DNA from other mycobacterial species. Identification accuracy of the
MAC multiplex was evaluated by testing 53 bacterial reference strains consisting of 28 different mycobacterial
species and 12 nonmycobacterial species. Identification accuracy in a clinical setting was evaluated for 223
clinical MAC isolates independently identified by other methods. Isolate identification agreement between the
MAC multiplex and these comparison assays was 100%. The novel MAC multiplex is a rapid, reliable, and
simple assay for discrimination of MAC species and subspecies in liquid culture media.
Since the early 1980s, there has been an increase in disease
caused by organisms broadly categorized as nontuberculous
mycobacteria (NTM), a generic term for mycobacteria not in
the Mycobacterium tuberculosis complex and other than M.
leprae (32). Of these NTM, Mycobacterium avium complex
(MAC) species are the most common cause of human and
animal disease globally (6, 14, 16, 24). The clinical relevance of
the MAC in humans has been amplified in recent decades with
the increasing population of immunocompromised individuals
resulting from longer life expectancy, immunosuppressive che-
motherapy, and the AIDS pandemic (27). The MAC is divided
into two main species: M. avium and M. intracellulare. M. avium
is further subdivided (per Turenne et al.) into four subspecies:
M. avium subsp. avium, M. avium subsp. hominissuis, M. avium
subsp. paratuberculosis, and M. avium subsp. silvaticum (39).
Members of the family Mycobacteriaceae, comprising the
MAC, differ in virulence and ecology. Those designated M.
avium subsp. hominissuis are genomically diverse, low-viru-
lence, opportunistic pathogens for both animals and humans.
The majority of human M. avium subsp. hominissuis infections
occur in HIV-immunocompromised people, immunocompe-
tent persons with underling pulmonary disease, and children
with cystic fibrosis (2, 12, 17). Considered ubiquitous in the
environment (the most likely source of infection for humans),
M. avium subsp. hominissuis has been isolated from water, soil,
and dust (9). Domestic water distribution systems have been
reported as possible sources of M. avium subsp. hominissuis
infections in hospitals, homes, and commercial buildings (26,
27). In animals, M. avium subsp. hominissuis is found as a cause
of lymphadenitis of the head and mesenteric lymph nodes of
swine recognized at slaughter.
Mycobacterium avium subsp. avium has long been recog-
nized as a primary pathogen causing avian tuberculosis in wild
and domestic birds (37, 38). Members of this subspecies also
sporadically cause disease in other animals (6, 15, 30).
For veterinarians, the MAC member of greatest importance
is M. avium subsp. paratuberculosis. This MAC member causes
a chronic granulomatous enteritis called Johne’s disease or
paratuberculosis, most often in ruminants (16, 22, 31). Myco-
bacterium avium subsp. paratuberculosis is capable of infecting
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and causing disease a wide array of animal species, including
nonhuman primates, without need of immunosuppressive coin-
fections. The herd-level prevalence of M. avium subsp. paratu-
berculosis infections in dairy cattle exceeds 50% in most major
dairy product-producing countries (29, 31). Two systematic
reviews and meta-analyses report a consistent association of M.
avium subsp. paratuberculosis with Crohn’s disease, and the
zoonotic potential of M. avium subsp. paratuberculosis contin-
ues to be a controversial subject discussed in the literature (1,
11). Unlike for most other M. avium subspecies, isolation of M.
avium subsp. paratuberculosis requires the addition of the sid-
erophore mycobactin to culture media and prolonged culture
incubation for successful isolation from a tissue, soil, or fecal
samples (43). After this lengthy incubation period with special
media, resultant acid-fast organisms then need to be accurately
identified.
Unlike the M. avium subspecies, whose type strains were
obtained from nonhuman hosts, the type strain of M. intracel-
lulare (ATCC 13950) was isolated from a human, specifically a
child who died from disseminated disease. Recently, numerous
isolates considered to be M. intracellulare were reclassified as
M. chimaera sp. nov. as part of the MAC (35). Few of these
isolates were found to be clinically relevant, suggesting that
this MAC species has low pathogenicity, and this factor is
crucial to therapeutic decision making. Mycobacterium intra-
cellulare appears to have a distinct environmental niche, more
prevalent in biofilms and at significantly higher CFU numbers
than M. avium (10, 36). It accounts for more documented
human infections than M. avium subsp. hominissuis in several
countries, including South Korea and Japan (19, 20, 23).
Contemporary methods for MAC identification, e.g., high-
performance liquid chromatography (HPLC) of cell wall my-
colic acids, and genetic probes based on rRNA targets, e.g.,
AccuProbe, cannot discriminate among M. avium subspecies
(2, 9). Given the differences in pathogenicity among M. avium
subspecies and the implications regarding the infection source,
a practical and accurate method of simply identifying M. avium
subspecies is needed (13, 25, 35). In this study, we describe the
specificity, discrimination capacity, and sensitivity of a novel
five-target PCR, called the MAC multiplex, using a wide array
of reference and clinical MAC isolates and numerous nonmy-
cobacterial organisms.
MATERIALS AND METHODS
Primer design and MAC multiplex PCR assay. Based on the sequences of
IS900 (GenBank accession no. X16293), IS901 (accession no. X59272), IS1311
(accession no. U16276), DT1 (accession no. L04543), and the 16S rRNA gene
(34), primer sets were designed to amplify specific portions of each target gene
(Table 1). Assay conditions were optimized in previous studies (41). For ampli-
fication, an aliquot (2 l) of the DNA sample was added to 48 l of PCR mixture
containing 10 mM Tris-HCl (pH 8.8), 2.5 mM MgCl2, 50 mM KCl, 1 M betaine,
0.2 mM each deoxynucleoside triphosphate (Promega, Madison, WI), 10 pmol of
each primer, and 2.5 U of HotStar Plus Taq polymerase (Qiagen, Gaithersburg,
MD). After an initial denaturation step (8 min at 95°C) to activate the HotStar
Plus Taq polymerase, 29 cycles of amplification were performed as follows:
denaturation at 95°C for 60 s, annealing at 60°C for 40 s, and DNA extension at
72°C for 35 s. A final extension was performed at 72°C for 10 min. Amplification
was carried out in a DNA 9700 thermocycler (TGradient; Biometra, Germany).
After amplification, PCR products were analyzed on a 2.0% agarose gel, stained
with ethidium bromide, and visualized on a UV transilluminator. Multiplex PCR
products of 484, 398, 753, 608, and 296 bp resulted from amplification of the 16S
rRNA gene, IS900, IS901, IS1311, and DT1 targets, respectively (Fig. 1). DNA
isolated from M. avium subsp. paratuberculosis ATCC 19698, M. avium subsp.
avium ATCC 35712, M. intracellulare ATCC 13950, and M. terrae ATCC 15755
were used as controls for each primer set in each PCR run.
A priori MAC multiplex interpretation criteria, consistent with current MAC
nomenclature (39), are listed in Table 2. Simultaneous amplification of the three
targets IS1311, the 16S rRNA gene, and IS900, was interpreted as corresponding
to M. avium subsp. paratuberculosis; amplification of DT1, IS1311, the 16S rRNA
gene, and IS901 was interpreted as corresponding to M. avium subsp. avium
serotype 2 or 3 (“bird type”) or M. avium subsp. silvaticum. Amplification of both
IS1311 and the 16S rRNA gene but neither IS900 nor IS901 was interpreted as
corresponding to M. avium subsp. hominissuis. Amplification of only the DT1
and 16S rRNA gene targets indicated M. intracellulare. Mycobacterial species
outside the MAC were indicated when 16S rRNA gene amplification alone was
observed.
Bacterial strains, cultures, and preparation of mycobacterial single-cell sus-
pensions. The origins, sources and/or strain names, descriptions, and reference
identifications of mycobacterial strains used to evaluate the assay are listed in
Table 3. Reference strains of each Mycobacterium species were obtained from
the American Type Culture Collection (ATCC). All nonmycobacterial organisms
were obtained from the ATCC or the State Laboratory of Hygiene, Madison, WI
(WSLH). Mycobacteria were cultivated in 7H9 broth supplemented with 10%
oleic acid-albumin-dextrose-catalase (OADC; Difco Laboratories, MD) supple-
mented with 2 g/ml of mycobactin J (Allied Monitor, Fayette, MO) for 2 weeks
(rapid growers) or 4 weeks (slow growers) at 37°C. Nonmycobacterial organisms,
such as Escherichia coli, were grown in Luria-Bertani (LB) liquid medium for 2
TABLE 1. Oligonucleotide primers used for MAC multiplex PCR
Genetic construct Productsize (bp) Orientation
a Oligonucleotide sequence Target organism(s)
IS900 398 F 5 TGGACAATGACGGTTACGGAGGTGG 3 M. avium subsp. paratuberculosis
R 5 CGCAGAGGCTGCAAGTCGTGG 3
IS901 753 F 5 GAACGCTGCTCTAAGGACCTGTTGG 3 M. avium subsp. avium
R 5 GGAAGGGTGATTATCTGGCCTGC 3
DT1 296 F 5 CGTTGGCTGGCCATTCACGAAGGAGT 3 M. avium subsp. avium and
R 5 GCTAGTTGGATCGCGCCGAACACCGG 3 M. intracellulare
IS1311 608 F 5 GCGTGAGGCTCTGTGGTGAA 3 All MAC members
R 5 ATGACGACCGCTTGGGAGAC 3
16S rRNA gene 484 F 5 ATAAGCCTGGGAAACTGGGT 3 All mycobacterial species
R 5 CACGCTCACAGTTAAGCCGT 3
a F, forward; R, reverse.
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days. All bacteria were washed 3 times with 10 mM phosphate-buffered saline
(PBS; pH 7.4), bacterial cell pellets were collected after centrifugation, and small
aliquots were stored at 80°C until use.
DNA extraction. To prepare the bacterial DNA from pure cultures, 1 ml of the
bacterial pellet was resuspended in 10 mM PBS (pH 7.4) and transferred into a
1.5-ml Eppendorf tube. The DNA was extracted by using either a QIAamp DNA
stool minikit (Qiagen Inc., Valencia, CA) or the conventional cetyltrimethyl-
ammonium bromide (CTAB) method (18) following procedures described pre-
viously (3) or as described by the manufacturer, with minor modifications.
Multiplex specificity and sensitivity. To determine MAC multiplex specificity,
a total of 53 reference bacterial strains consisting of 28 different mycobacterial
species and 12 nonmycobacterial species were tested (Table 3). To evaluate assay
sensitivity, purified DNA from M. avium subsp. avium ATCC 35712, M. avium
subsp. paratuberculosis ATCC 19698, M. avium subsp. hominissuis 104, M. intra-
cellulare ATCC 13950, M. abscessus ATCC 19977, M. tuberculosis Ra, M. bovis
BCG, E. coli ATCC 35218, and M. terrae ATCC 15755 isolated from pure
cultures were serially diluted from 100 ng to 5 fg, then assayed using the MAC
multiplex.
MAC multiplex PCR on clinical isolates from broth culture. A total of 223
MAC strains, consisting of 117 isolates of M. avium subsp. paratuberculosis, 80
isolates of M. avium subsp. hominissuis, 3 isolates of M. avium subsp. avium, and
23 isolates of M. intracellulare were obtained from human and veterinary diag-
nostic laboratories. The origins and sources of these isolates are listed in Table
4. The M. avium subsp. paratuberculosis isolate identities had been confirmed by
both analysis of L1 and L9 and single-target IS900 PCR detection (28). The
human-origin M. avium subsp. paratuberculosis isolates were identified by using
a previously described molecular typing method based on two IS900 integration
loci (28), IS1311 restriction fragment length polymorphism (21), rpoB sequence
analysis (5), and hsp65 code sequevar analysis (19, 40). All clinical isolates were
tested by MAC multiplex PCR on a blind basis after their propagation in
modified Bactec 12B or MGIT ParaTB culture media.
RESULTS
Specificity and sensitivity of MAC multiplex PCR. The
MAC multiplex PCR’s five products were readily visualized on
agarose gels: these products were a 484-bp product specific for
the mycobacterial 16S rRNA gene, a 398-bp product from
IS900 specific for M. avium subsp. paratuberculosis, 753 bp
from IS901 specific for M. avium subsp. avium, 296 bp from DT
found in M. avium subsp. avium and M. intracellulare, and a
608-bp product from IS1311 found in all M. avium subspecies
members (Fig. 1). During testing of the 12 nonmycobacterial
FIG. 1. Representative gel resulting from the MAC multiplex. Lane M, molecular size marker; lane 1, M. avium subsp. avium ATCC 35712;
lane 2, M. avium subsp. paratuberculosis ATCC 19698; lane 3, M. avium subsp. hominissuis 104; lane 4, M. intracellulare ATCC 13950; lane 5, M.
terrae ATCC 15755; lane 6, M. phlei ATCC 11758; lane 7, Mycobacterium abscessus ATCC 19977; lane 8, M. tuberculosis Ra; lane 9, Mycobacterium
bovis (BCG); lane 10, E. coli ATCC 35218; lane 11, negative control.
TABLE 2. Interpretation criteria for MAC multiplex results
Identification
Criterion
Panmycobacterium
16S rRNA gene IS900 IS901 IS1311 DT1
M. avium subsp. avium (serotypes 2 and 3) or
M. avium subsp. silvaticuma
    
M. avium subsp. avium (serotype 1)     
M. avium subsp. paratuberculosis     
M. avium subsp. hominissuis     
M. intracellulare     
Mycobacteria other than MAC     
Nonmycobacterial species     
a An M. avium subspecies rarely isolated and of uncertain taxonomic status.
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species, no amplification was seen for any of the MAC multi-
plex targets. The MAC multiplex correctly positioned the
ATCC mycobacterial species within or outside the M. avium
complex and identified all species within the MAC correctly
(Table 1).
Based on dilution trials with purified DNA from M. avium
subsp. paratuberculosis ATCC 19698, M. avium subsp. avium
ATCC 35712, M. intracellulare ATCC 13950, and M. bovis
(BCG), the analytical sensitivities of the MAC multiplex PCR
were approximately 2 to 5 fg for the 16S rRNA gene, 10 fg for
IS900, 10 fg for IS901, 5 fg for IS1311, and 50 fg for DT1 (data
not shown). This is roughly equivalent to 101 to 102 CFU/ml of
mycobacteria in liquid culture. The MAC multiplex was able to
detect M. avium subsp. paratuberculosis from a mixed pure
culture containing a hundredfold excess of non-MAC myco-
bacteria (data not shown).
Performance of MAC multiplex with clinical isolates. Com-
plete identity agreement was found between the MAC multi-
plex and the independent methods used by source institutions
providing the 223 different acid-fast strains isolated from hu-
mans and a wide variety of domestic and nondomestic animals
(Table 4).
TABLE 3. Type strains used in the specificity test for multiplex PCR
Bacterial species
No. of
isolates
tested
Strain name(s)/sourcea
Amplification target in PCR
16S rRNA
gene IS900 IS901 IS1311 DT1
M. avium complex
M. avium subsp. paratuberculosis 6 K-10, ATCC 19698, ATCC 43015, ATCC 43544,
ATCC 43545, ATCC 49164
    
M. avium subsp. hominissuis 2 ATCC 700898, 104     
M. avium subsp. avium 2 ATCC 35712, ATCC 25291     
M. intracellulare 2 ATCC 13950, ATCC 25122     
M. avium subsp. silvaticum 1 ATCC 49884     
Mycobacteria other than MAC
M. abscessus 1 ATCC 19977     
M. bovis 1 ATCC 19210     
M. bovis BCG 1 BCG Pasteur 1173P2     
M. celatum 2 ATCC 51130, ATCC 51131     
M. chelonae 1 ATCC 35749     
M. flavescens 1 ATCC 14474     
M. fortuitum 2 ATCC 49403, ATCC 49404     
M. gastri 1 ATCC 15754     
M. gordonae 1 ATCC 14470     
M. kansasii 1 ATCC 12478     
M. malmoense 1 ATCC 29571     
M. marinum 1 ATCC 927     
M. nonchromogenicum 1 ATCC 19530     
M. peregrinum 1 ATCC 14467     
M. phlei 1 ATCC 11758     
M. scrofulaceum 1 ATCC 19981     
M. smegmatis 2 ATCC 14468, mc2155     
M. terrae 1 ATCC 15755     
M. tuberculosis H37Ra 1 ATCC 25177     
M. tuberculosis H37Rv 1 ATCC 25618     
M. ulcerans 1 ATCC 19423     
M. vaccae 1 ATCC 15483     
M. xenopi 1 ATCC 19250     
Bacteria (nonmycobacteria)
Enterobacter aerogenes 1 WSLH     
Escherichia coli 3 ATCC 25922, ATCC 35218, DH5     
Enterococcus faecalis 1 ATCC 29212     
Pseudomonas aeruginosa 1 WSLH     
Corynebacterium pseudotuberculosis 1 JTC     
Bacteroides fragilis 1 ATCC 25285     
Staphylococcus aureus 1 ATCC 29213     
Nocardia asteroides 1 WSLH     
Nocardiopsis dassonvillei 1 WSLH     
Nocardia farcinica 1 WSLH     
Streptomyces rimosus 1 WSLH     
Rhodococcus equi 1 WSLH     
Total 53
a ATCC, American Type Culture Collection, Manassas, VA; JTC, Johne’s Testing Center, Madison, WI; WSLH, Wisconsin State Laboratory of Hygiene,
Madison, WI.
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DISCUSSION
Insertion elements found in MAC subspecies provide useful
markers for their identification through genotyping (2, 4, 21,
39). Moreover, the markers appear to be associated with the
subspecies’ epidemiologies and pathogenicities, making the
use of these markers clinically relevant. With rare exceptions,
IS900 is a reliable genetic marker defining M. avium subsp.
paratuberculosis (4, 16), the cause of paratuberculosis (Johne’s
disease) in animals. IS901 is strongly associated with MAC
infections in avian species, and IS901-positive strains are thus
often called bird-type MAC members (7, 8, 39). IS1311 is
consistently associated with the MAC, with only rare excep-
tions reported (2, 21). Inclusion of primers for the 16S rRNA
gene target common to all mycobacteria in the MAC multiplex
serves as an internal control for confirmation of mycobacterial
identification (34).
Reliance on a single target for a collection of organisms so
closely related can be perilous and may result in inaccurate
diagnoses of mycobacterial infections (9). The MAC multiplex
has good analytical sensitivity (5 to 10 fg DNA), especially
considering that it simultaneously amplifies five separate my-
cobacterial genomic targets. The assay is designed specifically
to discriminate among MAC subspecies and is particularly
good at identifying M. avium subsp. paratuberculosis, aided in
all likelihood by the high copy number of IS900 (1). M. avium
subsp. paratuberculosis identification based solely on the detec-
tion of IS900 should be evaluated with caution, since some
environmental mycobacteria have been reported to contain
IS900-like elements (1, 14, 42).
Despite the specificity of PCR primers and the full isolate
identification concordance shown in this study’s data set, the
presence of more than one mycobacterial species in a sample
can perturb the diagnosis. False-positive PCR results are not
unheard of (33). Primer inhibition due to sample components
or competition for primer targets in the assay also may occur
and should be monitored.
The data provided from multitarget PCR allow discrimina-
tion among MAC subspecies, increase diagnostic confidence in
the identity of isolates, and help resolve discrepancies. This
technique is not only very promising for clear characterization
of clinical MAC infections but is useful for epidemiologic stud-
ies as well.
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